Major depressive disorder affects approximately 15 million American adults in the U.S. in a given year, and a first pharmacological line of defense is often a prescription for an SSRI such as Prozac, Celexa, or Zoloft. (These drugs have been favored since the late 1980s for the treatment of depression as they are generally well [...]

[Read more →]

Well, actually, I’m sure there’s more than one thing. Like, for example, we can assume they both make backroom deals, and they both know that money talks.
But there’s something else.
Both are unfairly trashing the legitimacy of licensed Canadian pharmacies — real, honest-to-goodness, brick-and-mortar pharmacies that have been inspected and approved to sell prescription medications [...]

[Read more →]

I received the following message the other day from one of our blog’s readers, Susanna Brooks:
I cannot believe that I cannot buy drugs in Canada (with a prescription). It’s been the only way that I can get some of the medications that I need that are ungodly expensive in the United States. [...]

[Read more →]

We’re written before about U.S. Senator David Vitter’s quixotic fight to legalize the purchase of Canadian drugs by Americans — long after the battle over reimportation has been lost in a thick haze of Big Pharma backroom bargaining with the White House.
Last week, Vitter — a Republican — took some heat from liberals by explaining [...]

[Read more →]

The pharmaceutical industry, through its lobbying group PhRMA, has promised to cut drug prices for certain Medicare Part D recipients and others by $80 billion over the next decade. In return, the Obama Administration has promised not to reform the pharmaceutical industry — no new regulations, no Medicare negotiation for lower drug prices, no [...]

[Read more →]

I recently saw yet another op-ed in another newspaper by another Big Pharma shill — you know, someone handed his talking points and told to go at it.
You can tell they’re a shill when they make exactly the same argument, point by point, as all the other shills make. You also know they’re a [...]

[Read more →]

I’ve guess I’ve finally come back to my senses.
After years of being cynical about our political system’s capability of doing anything but accumulating debt, I somehow thought Obama could make a difference. I thought, among other things, that meaningful healthcare reform was finally on its way.
But the system itself is more powerful than Obama [...]

[Read more →]

With the best-selling osteoporosis drug Fosamax on trial amid allegations that it causes “jaw death” in patients, you might think healthcare consumers would rejoice at the prospect of a new alternative to Fosamax on the market.
You might think that — until you look at the price.
The new drug, Amgen’s Prolia (denosumab), is up for approval [...]

[Read more →]

As those following the healthcare debate are aware, President Obama has backed off his campaign promises to legalize drug reimportation and require drug companies to negotiate drug prices with Medicare. Apparently deciding that healthcare reform would be defeated if he had to fight both Big Insurance and Big Pharma, he has decided to let [...]

[Read more →]

Above is a photograph by Eric Seals of the Detroit Free Press. It depicts James and Geraldine Keon, who for the past three years have regularly purchased their prescription drugs from Canada.
The Free Press profiles the Keons and other Americans who use Canadian pharmacies as part of a story on drug reimportation published over [...]

[Read more →]